Skip to Main Content

Paper Details

Estrogen receptor beta expression in triple negative breast cancers is not associated with recurrence or survival.
BMC Cancer
2
2023
BCa, ER, ER1, ER1 positive tumor cells, Estrogen, Estrogen receptor beta, HER2, PPG5-10 antibody, PR, TNBC, TNBC cancers, TNBC tumors, TNBC tumours, Triple negative BCa, estrogen, estrogen (, human, human epidermal growth factor receptor 2, patients, progesterone, progesterone (PgR) receptors, tamoxifen, triple, triple negative breast cancers, tumors
Author NameAffiliation
David Clouston
Graham G Giles
Graham G GilesUniversity of Melbourne
Graham G GilesSchool of Clinical Sciences at Monash Health, Monash University
Kylie L GorringeUniversity of Melbourne
Kylie L GorringePeter MacCallum Cancer Centre
Kara L BrittPeter MacCallum Cancer Centre
Kara L BrittUniversity of Melbourne
  • 1 - 8

Datasets

Release 1.2